IL135659A0 - Method of reducing craving in mammals - Google Patents

Method of reducing craving in mammals

Info

Publication number: IL135659A0
Authority: IL; Israel
Prior art keywords: mammals; reducing craving; craving; reducing
Prior art date: 1997-10-28

Application number

IL13565998A

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-28

Filing date

1998-10-26

Publication date

2001-05-20

1998-10-26 Application filed by Schering Corp filed Critical Schering Corp

2001-05-20 Publication of IL135659A0 publication Critical patent/IL135659A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Addiction (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL13565998A 1997-10-28 1998-10-26 Method of reducing craving in mammals IL135659A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95921397A	1997-10-28	1997-10-28
PCT/US1998/022255 WO1999021540A2 (en)	1997-10-28	1998-10-26	Method of reducing craving in mammals

Publications (1)

Publication Number	Publication Date
IL135659A0 true IL135659A0 (en)	2001-05-20

Family

ID=25501785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13565998A IL135659A0 (en)	1997-10-28	1998-10-26	Method of reducing craving in mammals

Country Status (16)

Country	Link
EP (1)	EP1043980A2 (en)
JP (1)	JP2001520989A (en)
KR (1)	KR20010031470A (en)
CN (1)	CN1283116A (en)
AR (1)	AR015984A1 (en)
AU (1)	AU1110099A (en)
BR (1)	BR9814830A (en)
CA (1)	CA2308453A1 (en)
CO (1)	CO4970824A1 (en)
HU (1)	HUP0100115A2 (en)
IL (1)	IL135659A0 (en)
NO (1)	NO20002149L (en)
PE (1)	PE122299A1 (en)
SK (1)	SK5812000A3 (en)
WO (1)	WO1999021540A2 (en)
ZA (1)	ZA989786B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR018297A1 (en) *	1998-03-02	2001-11-14	Schering Corp	USE OF A D1 / D5 ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OBSESSIVE COMPULSIVE DISORDERS, SOMATOFORM DISORDERS, DISTOCIATIVE DISORDERS, EAT DISORDERS, PULSE CONTROL AND AUTISM DISORDERS
US6410527B1 (en) *	1998-03-02	2002-06-25	Schering Corporation	Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
US6890951B2 (en)	1998-08-05	2005-05-10	Brookhaven Science Associates Llc	Treatment of addiction and addiction-related behavior
US6541520B1 (en)	1998-08-05	2003-04-01	Brookhaven Science Associates	Treatment of addiction and addiction-related behavior
IL137937A0 (en) *	1999-08-27	2001-10-31	Pfizer Prod Inc	A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en)	2000-10-23	2002-05-28	Brookhaven Science Associates, Llc	Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en)	2001-05-14	2002-10-08	Brookhaven Science Associates, Llc	Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
AU2002354017B2 (en)	2001-11-05	2007-08-16	Krele Pharmaceuticals, Inc.	Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
KR20130132774A (en)	2010-09-01	2013-12-05	토닉스 파마슈티컬스, 아이엔씨.	Treatment for cocaine addiction
CA2879020C (en)	2012-07-12	2021-02-09	Psyadon Pharmaceuticals, Inc.	Fused benzazepines for treatment of tourette's syndrome
DK3057595T3 (en) *	2013-10-18	2020-08-10	Emalex Biosciences Inc	Molten benzazepines for the treatment of the strain
CN110327350B (en) *	2019-07-11	2021-02-23	温州医科大学	Application of dopamine D1 receptor antagonist SCH39166 as a drug for the treatment of ocular pathological angiogenesis
CN110833621A (en) *	2019-12-06	2020-02-25	中国医科大学	Application of dopamine receptor 1 antagonists in the preparation of drugs for the treatment of schizophrenia-like mice induced by ketamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5607967A (en) *	1994-10-27	1997-03-04	Merck & Co., Inc.	Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
AU3408097A (en) *	1996-06-06	1998-01-05	Ergo Research Corporation	Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists

1998
- 1998-10-26 CO CO98062495A patent/CO4970824A1/en unknown
- 1998-10-26 BR BR9814830-3A patent/BR9814830A/en not_active Application Discontinuation
- 1998-10-26 KR KR1020007004505A patent/KR20010031470A/en not_active Withdrawn
- 1998-10-26 WO PCT/US1998/022255 patent/WO1999021540A2/en not_active Ceased
- 1998-10-26 SK SK581-2000A patent/SK5812000A3/en unknown
- 1998-10-26 HU HU0100115A patent/HUP0100115A2/en unknown
- 1998-10-26 JP JP2000517699A patent/JP2001520989A/en not_active Withdrawn
- 1998-10-26 CN CN98812730A patent/CN1283116A/en active Pending
- 1998-10-26 IL IL13565998A patent/IL135659A0/en unknown
- 1998-10-26 AU AU11100/99A patent/AU1110099A/en not_active Abandoned
- 1998-10-26 CA CA002308453A patent/CA2308453A1/en not_active Abandoned
- 1998-10-26 EP EP98953826A patent/EP1043980A2/en not_active Withdrawn
- 1998-10-27 ZA ZA989786A patent/ZA989786B/en unknown
- 1998-10-27 PE PE1998001010A patent/PE122299A1/en not_active Application Discontinuation
- 1998-10-27 AR ARP980105373A patent/AR015984A1/en unknown
2000
- 2000-04-27 NO NO20002149A patent/NO20002149L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0100115A2 (en)	2001-06-28
NO20002149D0 (en)	2000-04-27
WO1999021540A3 (en)	1999-09-02
CO4970824A1 (en)	2000-11-07
PE122299A1 (en)	1999-12-04
EP1043980A2 (en)	2000-10-18
WO1999021540B1 (en)	1999-10-28
BR9814830A (en)	2000-10-03
WO1999021540A2 (en)	1999-05-06
CA2308453A1 (en)	1999-05-06
ZA989786B (en)	1999-04-28
SK5812000A3 (en)	2000-12-11
KR20010031470A (en)	2001-04-16
JP2001520989A (en)	2001-11-06
CN1283116A (en)	2001-02-07
AU1110099A (en)	1999-05-17
NO20002149L (en)	2000-06-26
AR015984A1 (en)	2001-05-30

Publication	Publication Date	Title
IL127912A0 (en)	1999-11-30	Method of activating dendritic cells
IL125829A0 (en)	1999-04-11	Method of sharing cryptokey
GB2311695B (en)	1999-12-01	Method of and telephone with call-reminding and auto-dialing
PL332741A1 (en)	1999-10-11	Battery and method of making same
GB2298713B (en)	1999-12-15	Method and composition
ZA989400B (en)	1999-04-15	Method and composition
PL339770A1 (en)	2001-01-02	Stator and method of making same
PL334918A1 (en)	2000-03-27	Stator and method of making same
IL135659A0 (en)	2001-05-20	Method of reducing craving in mammals
EP0716478A3 (en)	1997-04-23	Electrical connection structure and method
ZA989398B (en)	1999-04-15	Method and composition (l)
PL326102A1 (en)	1998-11-09	Decorative laminate and method of making same
GB9626906D0 (en)	1997-02-12	Method of blow-moulding
GB2323745B (en)	2001-10-17	System and method relating to telecommunications
GB2332181B (en)	2001-10-31	Method of synchronizing first and second steering arrangements
GB2318356B (en)	1999-03-10	Composition and method
HK1030550A (en)	2001-05-11	Method of reducing craving in mammals
GB2311218B (en)	2000-02-02	Improvements in and relating to baths
GB9726186D0 (en)	1998-02-11	Method of moulding
PL314704A1 (en)	1997-12-08	Method of obtaining pure cadmium
IL117256A0 (en)	1996-08-04	Method of manufacturing an intermediate of kvass
GB9626046D0 (en)	1997-01-29	Methods of manufacturing engines
PL322291A1 (en)	1999-03-29	Structural component and method of making same
PL320015A1 (en)	1998-11-23	Method of obtaining 4-chloro-2-methylphenylacetic acid in solid form
TW297376U (en)	1997-02-01	Structure of scooter